Search for other papers by Yuegui Wang in
Google Scholar
PubMed
Search for other papers by Liwei Hong in
Google Scholar
PubMed
School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian, China
Search for other papers by Caiyun Yang in
Google Scholar
PubMed
Quanzhou Medical College, Quanzhou, Fujian, China
Search for other papers by Guorong Lv in
Google Scholar
PubMed
Search for other papers by Kangjian Wang in
Google Scholar
PubMed
Search for other papers by Xuepeng Huang in
Google Scholar
PubMed
Search for other papers by Haolin Shen in
Google Scholar
PubMed
orbitopathy ( 5 ). Therapies for GD include antithyroid drugs (ATDs), thyroidectomy, or radioactive iodine (RAI) therapy. ATD has only a 50% success rate for most patients after 1 year of treatment, and it may cause side effects such as agranulocytosis
Search for other papers by Eugenie S Lim in
Google Scholar
PubMed
Search for other papers by Shanty G Shah in
Google Scholar
PubMed
Search for other papers by Mona Waterhouse in
Google Scholar
PubMed
Barts and the London School of Medicine and Dentistry, QMUL, London, UK
Search for other papers by Scott Akker in
Google Scholar
PubMed
Barts and the London School of Medicine and Dentistry, QMUL, London, UK
Search for other papers by William Drake in
Google Scholar
PubMed
Barts and the London School of Medicine and Dentistry, QMUL, London, UK
Search for other papers by Nick Plowman in
Google Scholar
PubMed
Barts and the London School of Medicine and Dentistry, QMUL, London, UK
Search for other papers by Daniel M Berney in
Google Scholar
PubMed
Search for other papers by Polly Richards in
Google Scholar
PubMed
Search for other papers by Ashok Adams in
Google Scholar
PubMed
Search for other papers by Ewa Nowosinska in
Google Scholar
PubMed
Search for other papers by Carmel Brennan in
Google Scholar
PubMed
Barts and the London School of Medicine and Dentistry, QMUL, London, UK
Search for other papers by Maralyn Druce in
Google Scholar
PubMed
received either ‘traditional’ or low-dose ablation. Prior to therapy, patients were advised to eat a diet low in iodine for 1–2 weeks and all doses were administered under conditions of high TSH, predominantly achieved with recombinant TSH. Patients were
Search for other papers by Norra Kwong in
Google Scholar
PubMed
Search for other papers by Ellen Marqusee in
Google Scholar
PubMed
Division of Endocrinology, Endocrine Division, Hypertension and Diabetes, Thyroid Section, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Avenue Boston, Massachusetts 02115, USA
Search for other papers by Michael S Gordon in
Google Scholar
PubMed
Search for other papers by P Reed Larsen in
Google Scholar
PubMed
Division of Endocrinology, Endocrine Division, Hypertension and Diabetes, Thyroid Section, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Avenue Boston, Massachusetts 02115, USA
Search for other papers by Jeffrey R Garber in
Google Scholar
PubMed
Search for other papers by Matthew I Kim in
Google Scholar
PubMed
Search for other papers by Erik K Alexander in
Google Scholar
PubMed
radioactive iodine (RAI) ( 131 I) ablation, followed by thyroid hormone suppression therapy (6, 7, 8, 9) . Though there may be benefits to this approach, especially for patients with advanced disease, increasing evidence confirms that such a standardized
Search for other papers by Adriano N Cury in
Google Scholar
PubMed
Search for other papers by Verônica T Meira in
Google Scholar
PubMed
Pediatric Endocrinology Unit, Endocrinology and Metabolism, Nuclear Medicine Laboratory, Pediatrics Department, Irmandade da Santa Casa de Misericórdia de São Paulo, 01221-020 São Paulo, Brazil
Search for other papers by Osmar Monte in
Google Scholar
PubMed
Search for other papers by Marília Marone in
Google Scholar
PubMed
Search for other papers by Nilza M Scalissi in
Google Scholar
PubMed
Search for other papers by Cristiane Kochi in
Google Scholar
PubMed
Search for other papers by Luís E P Calliari in
Google Scholar
PubMed
Search for other papers by Carlos A Longui in
Google Scholar
PubMed
surgical procedure that can effect complications, depending on the surgeon's experience (1) . Radioactive iodine (RAI) therapy has been used frequently, especially in the USA (7) , as an alternative first-line therapy to surgery and ATDs. The incidence
Search for other papers by Keiko Ohkuwa in
Google Scholar
PubMed
Search for other papers by Kiminori Sugino in
Google Scholar
PubMed
Search for other papers by Mitsuji Nagahama in
Google Scholar
PubMed
Search for other papers by Wataru Kitagawa in
Google Scholar
PubMed
Search for other papers by Kenichi Matsuzu in
Google Scholar
PubMed
Search for other papers by Akifumi Suzuki in
Google Scholar
PubMed
Search for other papers by Chisato Tomoda in
Google Scholar
PubMed
Search for other papers by Kiyomi Hames in
Google Scholar
PubMed
Search for other papers by Junko Akaishi in
Google Scholar
PubMed
Search for other papers by Chie Masaki in
Google Scholar
PubMed
Search for other papers by Koichi Ito in
Google Scholar
PubMed
patients with DTC and is predominantly observed in the lungs and bone ( 3 , 4 , 5 , 6 ). When treating metastatic tumors of differentiated thyroid carcinoma, a favorable prognosis can be expected after radioactive iodine (RAI) therapy after total
Search for other papers by Guoquan Zhu in
Google Scholar
PubMed
Search for other papers by Yuying Deng in
Google Scholar
PubMed
Search for other papers by Liqin Pan in
Google Scholar
PubMed
Search for other papers by Wei Ouyang in
Google Scholar
PubMed
Search for other papers by Huijuan Feng in
Google Scholar
PubMed
Search for other papers by Juqing Wu in
Google Scholar
PubMed
Search for other papers by Pan Chen in
Google Scholar
PubMed
Search for other papers by Jing Wang in
Google Scholar
PubMed
Search for other papers by Yanying Chen in
Google Scholar
PubMed
Search for other papers by Jiaxin Luo in
Google Scholar
PubMed
to that of the wild-type group. One possible reason for this unexpected finding might be that all patients received postsurgical RAI therapy in our study. According to previous research, radioactive iodine (RAI) therapy, as an important adjuvant
Search for other papers by Lian Duan in
Google Scholar
PubMed
Search for other papers by Han-Yu Zhang in
Google Scholar
PubMed
Search for other papers by Min Lv in
Google Scholar
PubMed
Search for other papers by Han Zhang in
Google Scholar
PubMed
Search for other papers by Yao Chen in
Google Scholar
PubMed
Search for other papers by Ting Wang in
Google Scholar
PubMed
Search for other papers by Yan Li in
Google Scholar
PubMed
Search for other papers by Yan Wu in
Google Scholar
PubMed
Search for other papers by Junfeng Li in
Google Scholar
PubMed
Search for other papers by Kefeng Li in
Google Scholar
PubMed
validation set. RAI, radioiodine therapy; ROC, receiver operator characteristic curve; HT, hypothyroidism; NC, the normal control group; AST, aspartate aminotransferase; TRAb, thyrotropin-receptor antibodies; 24-h RAIU, radioactive iodine uptake at 24 h; TMA
Search for other papers by Danuta Gąsior-Perczak in
Google Scholar
PubMed
Search for other papers by Iwona Pałyga in
Google Scholar
PubMed
Search for other papers by Monika Szymonek in
Google Scholar
PubMed
Search for other papers by Artur Kowalik in
Google Scholar
PubMed
Search for other papers by Agnieszka Walczyk in
Google Scholar
PubMed
Search for other papers by Janusz Kopczyński in
Google Scholar
PubMed
Search for other papers by Katarzyna Lizis-Kolus in
Google Scholar
PubMed
Search for other papers by Anna Słuszniak in
Google Scholar
PubMed
Search for other papers by Janusz Słuszniak in
Google Scholar
PubMed
Search for other papers by Tomasz Łopatyński in
Google Scholar
PubMed
Search for other papers by Ryszard Mężyk in
Google Scholar
PubMed
The Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland
Search for other papers by Stanisław Góźdź in
Google Scholar
PubMed
The Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland
Search for other papers by Aldona Kowalska in
Google Scholar
PubMed
many cases, lobectomy (L) is sufficient as surgical treatment and radioactive iodine ( 131 I) therapy is often unnecessary ( 7 ). Much attention has been paid to personalizing the way the disease is monitored; however, research efforts have focused on
Search for other papers by Marek Niedziela in
Google Scholar
PubMed
.1530/EC-12-0049 ) 40 Kaplowitz PB Jiang J Vaidyanathan P . Radioactive iodine therapy for pediatric Graves’ disease: a single-center experience over a 10-year period . Journal of Pediatric Endocrinology and Metabolism 2020 33 383 – 389 . ( https
Search for other papers by Klaudia Zajkowska in
Google Scholar
PubMed
Search for other papers by Janusz Kopczyński in
Google Scholar
PubMed
Search for other papers by Stanisław Góźdź in
Google Scholar
PubMed
Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland
Search for other papers by Aldona Kowalska in
Google Scholar
PubMed
inclusion and exclusion criteria has an extremely indolent clinical behaviour, even when treated conservatively with lobectomy and without radioactive iodine therapy. Nevertheless, it cannot be considered as a benign lesion. The risk of adverse outcomes